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ABSTRACT 
Objectives: To determine clinical manifestations, prognostic 
factors, and therapeutic outcomes of severe pneumococcal 
infection. 
Methods: Hospitalized patients with specimens cultured pos- 
itive for Streptococcus pneumoniae were identified retrospec- 
tively by reviewing hospital records from 1992 to May 1998 at 
Siriraj Hospital. 
Results: Of 205 evaluable cases, 130 (63.4%) patients were 
male. Nineteen (9.3%) patients were less than 2 years old, 29 
(14.1%) were between 2 and 13 years, 99 (48.3%) were 
between 14 and 60 years, and 58 (28.3%) were over 60 years 
of age. From 1992 to 1997, the average admission rate was 
highest (36.4%) between January and March (range = 20-45%). 
Average admission rates during other periods ranged from 
20.0% to 23.1%. Pneumonia (50.7%) and acute exacerbation 
of chronic obstructive pulmonary disease or infected bronchi- 
ectasis or bronchopneumonia (21 .O%) were the most frequent 
diagnoses, followed by meningitis (14.6%) and primary sepsis 
without localized lesion (8.3%). The mortality rate during the 
first 7 days of hospitalization was 28.8%, and thereafter, 11.7%. 
The odds ratios (95% Cl) of old age, congestive heart failure, 
and alcoholism for death were 3.4 (1.4-8.2), 8.6 (0.97-76.1), 
and 8.0 (3.1-20.9) respectively. For pneumonitis only, mortal- 
iky rates among alcoholic and nonalcoholic patients were 76.9% 
and 39.6%, respectively (P = 0.025). 
Conclusions: Patients who were alcoholic, over 60 years of 
age, or had congestive heart failure were vulnerable to severe 
pneumococcal infection with significant mortality, in spite of 
proper selection of empirical antimicrobials. Diabetes mellitus 
and multiple myeloma also contributed to late mortality after 
7 days of hospitalization. 
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Streptococcus pneumoniae has long been a leading cause 
of community-acquired infection associated with signifi- 
cant morbidity and mortality. In developed countries, the 
incidence is estimated to be 50 to 200 cases per 100,000 
population and pneumococcal bacteremia occurs more 
frequently among children under the age of 5 years and 
among the elderly.‘,’ The infection can occur in appar- 
ently healthy people, although more frequently it affects 
patients with diabetes mellitus, splenectomy,3 advanced 
human immunodeficiency virus (HIV) infection, alco- 
holism, nephrotic syndrome, and immunosuppressive 
therapy. Until recent years pneumococci were uniformly 
susceptible to penicillin and cephalosporins; however, 
the widespread use of antimicrobials is claimed to 
account for numerous reports of emerging penicillin- 
resistant S. pneumoniae (PRP) from Thailand and else- 
where.4-6 The authors assessed the current situation of 
severe pneumococcal infection in terms of clinical man- 
ifestation and therapeutic outcome at Siriraj Hospital, 
Bangkok, Thailand. 
MATERIAL AND METHODS 
Hospitalized patients with cultures positive for S. pneu- 
moniue were identified retrospectively by reviewing hos- 
pital records from 1992 to May 1998 at Siriraj Hospital, 
a primary- and tertiary-care hospital with 2500 beds, 
located in Bangkok. Those with positive sputum cultures 
and without preceding symptoms or signs related to res- 
piratory tract infection were excluded. Demographic data, 
association with study diseases, type of infection, empir- 
ical antimicrobials, and therapeutic outcomes were 
extracted from the charts. Susceptibility reports of pneu- 
mococci to penicillin, cefotaxime, ceftriaxone, amoxi- 
cillin, and erythromycin, from the microbiology 
laboratory, were collected, but in many cases, these were 
unavailable. The minimal inhibitory concentration 
(MIC) of penicillin-resistant strains to penicillin G and 
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cefotaxime with E-test strip (AB Biodisk, Solna, Sweden) 
also was obtained for some blood isolates. 
Distribution of cases by admission period, age group, 
type of infection, and associated disease were analyzed; 
percentage susceptible results were shown according to 
type of specimen and antimicrobials. Mortality rates also 
were analyzed by age group, admission period, type of 
infection, and associated disease. Chi-square, two-sided 
test was used to indicate statistically significant differ- 
ences in mortality rates among the groups. 
RESULTS 
Positive cultures for S.pneumoniae were found in 309 
hospital records; however, data were not accessible for 46 
cases. Another 58 cases were excluded because S.pneu- 
moniae was isolated from sputa, without preceding clin- 
ical manifestations of respiratory tract infection. These 
patients were admitted for treatment of cerebrovascular 
disease, leukemia, or malignancy, and the causes of fever 
other than pneumococcal infection were apparent when 
hospital charts were retrospectively reviewed. The 
remaining 205 cases are the subjects of this report. 
One hundred and thirty (63.4%) patients were male; 
19 (9.3%) were younger than 2 years, 29 (14.1%) were 2 
to 13 years, 99 (48.3%) were 14 to 60 years, and 58 
(28.3%) were over 60 years of age. From 1992 to 1997, 
the total number of cases admitted between January and 
March was 71 (36.4%), between April and June, 39 
(20.0%), between July and September, 40 (20.5%) and 
between October and December, 45 (23.1%). The ranges 
of annual admission rates for the same period were 20 to 
45% for January to March, 10 to 33% for April to June, 15 
to 31% for July to September, and 12 to 36% for October 
to December (Table 1). 
The clinical manifestations of the study cases were 
as follows: acute pneumonia, 104 (50.7%) cases, acute 
exacerbation of chronic obstructive pulmonary disease or 
infected bronchiectasis or bronchopneumonia, 43 
(21 .O%), meningitis, 30 (14.6%), primary septicemia with- 
out initial obvious nidus, 17 (8.3%) primary peritonitis, 
8 (3.9%) septic arthritis, 2 (1.0%) and thoracic empyema 
1 (0.5%) case. 
A variety of diseases were associated with the infec- 
tion in 91 (44.4%) of the 205 cases. Specifically, alco- 
holism was diagnosed in 23 (11.2%) cases; nephrotic 
syndrome in 14 (6.8%) cases; systemic lupus erythe- 
matosus in 12 (5.9%) cases; diabetes mellitus and acute 
leukemia in 11 (5.4%) cases each; HIV infection in 10 
(4.9%) cases; hypertension in 9 (4.4%) cases; thalassemia 
in 6 (2.9%) cases; congestive heart failure due to ischemic 
heart disease or valvular heart disease in 6 (2.9%) cases; 
splenectomy in 4 (2.0%) cases; and multiple myeloma 
and chronic renal failure in 3 (1.5%) cases each (see 
Table 1). 
Table 1. Demographic and Clinical Data in 205 Cases 
Parameter Alumber of Cases (%,I Range (%) 
Male:female ratio 1.7: 1 
Age group (Y) 
<2 
2-13 
14-60 
> 60 
Admission rate* 
January-March 
April-June 
July-September 
October-December 
Type of Infection 
Pneumonia 
Acute exacerbation of COPD/ 
infected bronchiectasis/ 
bronchopneumonia 
Meningitis 
Primary septicemia 
Primary peritonitis 
Septic arthritis 
Thoracic empyema 
Association with study diseases 
Alcoholism 
Nephrotic syndrome 
Systemic lupus erythematosus 
Leukemia 
Diabetes mellitus 
HIV infection 
Hypertension 
Thalassemia 
Congestive heart failure 
Splenectomy 
Multiple myeloma 
Chronic renal failure 
19 (9.3) 
29 (14.1) 
99 (48.3) 
58 (28.3) 
71 (36.4) 
39 (20.0) 
40 (20.5) 
45 (23.1) 
104 (50.7) 
43 (21 .O) 
30 (14.6) 
17 (8.3) 
8 (3.9) 
2 (1.0) 
1 (0.5) 
91 (44.4) 
23 (11.2) 
14 (6.8) 
12 (5.9) 
11 (5.4) 
11 (5.4) 
10 (4.9) 
9 (4.4) 
6 (2.9) 
6 (2.9) 
4 (2.0) 
3 (1.5) 
3 (1.5) 
(20-45) 
(1 O-33) 
(I 5-31) 
(12-36) 
*Admission rate calculated for each year and on average using cases admitted 
during 1992 to 1997 only. COPD = chronic obstructive pulmonary disease. 
The susceptibility results by disk diffusion method 
were available for most isolates (Table 2). Intermediate 
resistance to penicillin was detected in 17 to 34% of 
blood isolates and 47 to 73% of isolates from sputa dur- 
ing 1994 to 1997. The MICs determined by E-test were 
available for 14 strains of PRP isolated from blood spec- 
imens and ranged from 0.1 to 1.5 mg/L. Five isolates 
showed the MICs to be less than 0.5 mg/L and eight iso- 
lates at 0.5 mg/L. One strain isolated from blood in 1997 
exhibited MICs for penicillin and cefotaxime at 1.5 and 
1.0 mg/L, respectively. All cerebrospinal fluid (CSF) iso- 
lates were susceptible to cefotaxime or ceftriaxone. 
Empirical antimicrobials were penicillin G sodium 
(36.6%) cefotaxime (14.1%) ceftriaxone (9.8%) ampi- 
cillin (8.8%), cefuroxime (4.3%) co-amoxiclav (3.9%), cef- 
tazidime (3.4%) imipenem (0.5%) vancomycin (0.5%), 
ciprofloxacin (2.0%) erythromycin (1 .O%>, co-trimoxa- 
zole (0.5%), and no antimicrobial (2.0%). The antimicro- 
bials were started on the first day of hospitalization in 175 
(85.4%) cases, the second day and third day in 9 (4.4%) 
cases each, the fourth day in 4 (2.0%) cases, and the fifth 
day or later in 8 (4.0%) cases. If appropriate, the antibiotic 
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Table 2. Percentage Susceptible of Pneumococci 
by Antimicrobial, Type of Specimen, and Year 
Year and Specimen Antimicrobial 
(Number of 
Strains Tested) Pen Ery Amox Cefo Ceft 
1994 
Blood (49) 76 86 98 100 100 
Sputum (2) 100 100 100 100 100 
CSF(1) 100 100 100 100 100 
1995 
Blood (47) 81 88 94 100 100 
Sputum (15) 53 67 100 100 100 
CSF(7) 43 43 100 100 100 
1996 
Blood (40) 83 88 96 100 100 
Sputum (10) 30 60 60 90 90 
CSF (5) 40 60 60 100 100 
1997 
Blood (41) 66 73 81 98 100 
Sputum (30) 27 57 70 100 100 
CSF (3) 33 33 100 100 100 
Pen = penicillin; ery = etythromycin; amox = amoxicillin; cefo = cefotaxime; ceft 
= ceftriaxone; CSF = cerebrospinal fluid. 
therapy was changed when the results of culture and sus- 
ceptibility testing were reported. 
Complete recovery or improvement was achieved in 
122 (59.5%) cases. Two (1%) cases were transferred to 
succumb at home. Death occurred within day 1 to 7 of 
hospitalization in 59 (28.8%) cases and after more than 
7 days in 24 (11.7%) cases. Thus total mortality was 83 
(40.5%) cases. The mortality rates during the first 5 and 
7 days of hospitalization were 25.2% and 28.8%, respec- 
tively. Death after 7 days of hospitalization was found to 
be 11.7%. Among the four age groups, mortality rate was 
found to be highest (63%) in the age group of 61 years 
or older. The mortality rate was highest (56%) during 
October to December; in other periods it ranged from 
30% to 36%. Primary septicemia and alcoholism were 
associated with the highest death rates (65% and 78%) by 
type of infection and associated disease, respectively. As 
shown in Table 3, differences in mortality rates between 
different age groups were statistically significant. 
Univariate analysis of all cases revealed that relative 
risk increase for death (RRI) was 2.7-fold for alcoholism, 
2.7-fold for congestive heart failure, and 2.0-fold for 
advanced age. By logistic regression analysis, the derived 
equation was 72% accurate for prediction of death. The 
RRI of old age for death was 3.4 (95% CI = 1.4-8.2) of 
alcoholism was 8.0 (95% CI = 3.1-20.9) and of conges- 
tive heart failure was 8.6 (95% CI = 0.97-76.1). In sepa- 
rated analysis for 104 patients with pneumonitis, 10 
(76.9%) of 13 cases with alcoholism died, whereas 36 
(39.6%) of 91 cases without alcoholism died, and the dif- 
ference in the mortality rates between the two groups 
reached statistical significance (P = 0.025). 
By observation, the prognosis was grave in cases with 
onset of shock occurring within 7 days of illness among 
alcoholics, with peripheral leukocyte counts of less than 
1500 cells/mm3 (2 cases), and with numerous bacteria 
(over 50 cells/oil-field) seen under microscopy with no 
or very few neutrophils in Gram-stained smears of CSF 
(2 cases). 
DISCUSSION 
It is clear that admissions to a tertiary-care hospital for 
pneumococcal infection represent only a small portion of 
the spectrum of the infection. Siriraj Hospital is the old- 
est tertiary-care government hospital in Thailand, where 
1.2 million patients are treated each year by the out- 
patient department. Although 2500 hospital beds exist, 
the waiting list for admission is long for nonemergency 
cases. Patients presenting with infections or pyrexia, must 
have moderate to severe symptoms to be selected for 
admission. Thus, other cases with noninvasive pneumo- 
coccal infections, such as acute otitis media, sinusitis, 
orbital cellulitis, or with culture-negative pneumococcal 
infection were not included in this study. 
Infection in adults constituted nearly half and the 
elderly 28.3% of total cases. Longevity among the Thai 
people puts the elderly at risk of development of pneu- 
mococcal infection, as found in developed countries. 
Unexpectedly, the admission rate during January to March 
was higher than during other periods; but this possibly 
is related to two festivals in January and February Con- 
ventional New Year and Chinese New Year are the times 
when laborers work hard to produce goods for sale. In- 
adequate physical rest may increase susceptibility to infec- 
tion. Approximately half of the cases manifested as acute 
pneumonia. Primary septicemia developed in 17 patients 
who initially had negligible focal symptoms, although the 
upper and lower respiratory tract often is claimed to be 
the nidus. Systemic reaction was exhibited more strik- 
ingly than local symptoms in these cases and may be 
related to an invasive virulence factor or factors of the 
organism rather than to poor host defense. Heavy bac- 
teremia may occur subsequently and result in positive 
blood cultures.’ Unfortunately, virulence factors or 
serotype of these isolates were not studied to confirm 
the hypothesis. Virulence factors may have been impli- 
cated in the cases of leukopenia, serious complications 
(e.g., adult respiratory distress syndrome or disseminated 
intravascular coagulation), or in cases in which numerous 
bacteria with few or no leukocytes were observed in the 
CSE This study revealed alcoholism was commonly asso- 
ciated with pneumococcal infection, and it provided an 
opportunity to study the contribution of alcoholism to 
therapeutic outcome in some types of infection. Pneu- 
mococcal infection was found in 10 HIV-infected patients. 
Since serologic testing for HIV infection is voluntary, it is 
possible that other HIV-infected cases with concomitant 
pneumococcal infection were missed. This finding is the 
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Table 3. Percentage of Mortality by Age Group, Admission Period, Type of Infection, and Associated Disease among 205 Cases 
Mortality Rate (%) 
1-7 day* > 7 day* Total (%) P-Value 
Total death 28.8 11.7 40.5 
Age group (Y) 0.004 
<2 5 5 IO 
2-13 10 3 13 
14-60 37 2 39 
> 60 41 22 63 
Admission period 0.322 
January-March 30 6 36 
AprilJune 20 16 36 
July-September 23 7 30 
October-December 40 16 56 
Type of infection 0.743+ 
Pneumonia 35 11 46 
Acute exacerbation of COPD, infected bronchiectasis, bronchopneumonia 14 7 21 
Meningitis 40 3 43 
Primary septicemia 65 0 65 
Primary peritonitis 12 12 24 
Septic arthritis 0 0 0 
Thoracic empyema 0 0 0 
Association with study diseases 0.838 
No(n=114) 30 8 38 
Yes (n = 91) 34 10 44 
Alcoholism 65 13 78 
Nephrotic syndrome 14 7 21 
Systemic lupus erythematosus 25 0 25 
Leukemia 27 9 36 
Diabetes mellitus 36 19 55 
HIV infection 20 0 20 
Hypertension 22 11 33 
Thalassemia 33 0 33 
Congestive heart failure 67 16 83 
Splenectomy 50 0 50 
Multiple myeloma 0 33 33 
Chronic renal failure 67 67 
*Hospitalization day; tprimaty peritonitis and septic arthritis were excluded from the analysis due to small sample size. 
first report in Thailand that confirms the predisposition 
of HIV infection to pneumococcal infection in Thai 
patients. 
Resistance to antimicrobials, penicillin G in particu- 
lar, is another emerging problem among recent pneu- 
mococcal isolates. Intermediate resistance to penicillin 
was detected in 17 to 34% of blood isolates and 47 to 73% 
of sputum isolates during 1994 to 1997. All CSF isolates 
were susceptible to cefotaxime or ceftriaxone. Until 1995, 
sputum isolates were assumed to be penicillin-suscepti- 
ble at this hospital and posed no therapeutic problem, 
since penicillin G sodium at 300,000 units/kg may be 
effective with relatively resistant strains. Even meningitis 
due to PRP (MICs for penicillin, 0.1-0.3 mg/L) may be 
managed successfully with penicillin G sodium at this 
dosage, as evidenced by subsequent negative culture in 
a few cases. Because cefotaxime or ceftriaxone are the 
two empirical drugs used to treat meningitis at the hos- 
pital, both should be effective, since 94.3% of penicillin- 
resistant or intermediate-resistant pneumococci were 
reported to be susceptible to ceftriaxone.8 This study did 
not correlate mortality rates with the susceptibility of 
pneumococcal isolates to the empirical antimicrobials, 
because the susceptibility result was not available in every 
case and, whenever available, confirmed that most of the 
empirical antimicrobials were active against PFU? In other 
studies, the mortality rates of infections due to penicillin- 
sensitive Spneumoniae and PRP were similar.9z10 Only 
one blood isolate in 1997 exhibited MICs for penicillin 
and cefotaxime at 1.5 and 1 .O mg/L, respectively by E-test. 
The finding of this isolate of nearly high-level PRP is a real 
threat to patients in Thailand. The role of microbiology 
laboratories in the detection of high-level penicillin-resis- 
tant pneumococci isolated from sterile sites is evident. 
Since PRP is frequently detected in nasopharyngeal iso- 
lates,” nasopharyngeal swab and culture is a sensitive 
and practical method for national surveillance of drug 
resistance.12 
The overall mortality rate in the present study was 
rather high (40.5%) compared to 15 to 21% of bacteremic 
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patients in developed country.‘~* When the cumulative 
mortality rate was broken down according to day of hos- 
pitalization, it was 25.2% at day 5 and 28.8% at day 7. 
After day 7, another 12.2% of patients succumbed. The 
authors chose to divide mortality rate by day 7 because 
the mortality rate reached a steady state after that day The 
mortality rates of 25.2% or 28.8% do not differ signifi- 
cantly from previous reports. It is well known that proper 
antimicrobial treatment is rarely effective in altering the 
outcome or death that occurred within 1 to 7 days of 
hospitalization. However, the late mortality of 12.2 to 
15.5% certainly contributes to the overall high mortality. 
Diabetes mellitus and multiple myeloma were found, in 
addition to advanced age and alcoholism, to contribute 
to the late mortality The so-called referral bias also con- 
tributed, because more severe cases were referred to Siri- 
raj Hospital and thus included in the analysis. Mortality 
was high during the winter season (October-December) 
when influenza is usually epidemic and known to 
contribute to pneumococcal disease predisposition and 
consequent mortality. This study strongly indicates that 
alcoholism was a major risk factor that increased the like- 
lihood of death in pneumonia by twofold. In Thailand, 
alcoholics usually have a poor nutritional state that weak- 
ens immunity. Old age is another significant factor that 
increases risk of death. Due to the small sample size (n 
= 6), congestive heart failure was statistically insignificant 
as a prognostic factor, but the upper limit of the 95% 
confidence interval of its odds ratio was high (95% 
CI = 0.97-76.1). 
Antimicrobials are generally regarded as ineffective in 
saving lives of those with rapidly progressive infection. 
Pneumococcal vaccination is an intervention that would 
reduce the incidence of invasive pneumococcal infection 
and prevent the early deaths. Although serotyping of 
pneumococci was not performed in this study, other stud- 
ies in Thailand have revealed that approximately 87 to 
90% of the isolates were included in the polysaccharide 
vaccine.13,‘* Efficacy of the vaccine exceeds 57% for pro- 
phylaxis of infection caused by serotypes represented in 
the vaccine.15s16 Whether pneumococcal vaccination 
among the Thai patients with high risk of pneumococ- 
cal infection and poor prognosis is cost-effective in the 
era of economic crisis remains to be seen. Simultaneous 
immunization with influenza and pneumococcal vaccines 
also is a challenging strategy for Thailand to overcome the 
high mortality rate of pneumococcal infection in the 
elderly during the winter season. 
In conclusion, severe pneumococcal infection still 
prevails with overall high mortality in developing coun- 
tries. Empirical therapy with appropriate antimicrobials 
is unable to reduce the early mortality. Continuous labo- 
ratory monitoring of the susceptibility to penicillin and 
cephalosporins is needed to determine the situation of 
antimicrobial resistance and to provide a basis for guide- 
lines for antimicrobial therapy. Preventive measures, such 
as reducing alcohol use, avoiding polluted or overcrowded 
environments,” and foremost, undergoing pneumococcal 
vaccination, should be seriously considered by those with 
high risk and poor prognosis, to avoid invasive pneumo- 
coccal infection. 
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